302 related articles for article (PubMed ID: 25409606)
1. Multifunctional enveloped nanodevices (MENDs).
Sato Y; Nakamura T; Yamada Y; Akita H; Harashima H
Adv Genet; 2014; 88():139-204. PubMed ID: 25409606
[TBL] [Abstract][Full Text] [Related]
2. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
3. Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistribution.
Nakamura T; Yamada Y; Sato Y; Khalil IA; Harashima H
Biomaterials; 2019 Oct; 218():119329. PubMed ID: 31306827
[TBL] [Abstract][Full Text] [Related]
4. "Programmed packaging" for gene delivery.
Hyodo M; Sakurai Y; Akita H; Harashima H
J Control Release; 2014 Nov; 193():316-23. PubMed ID: 24780263
[TBL] [Abstract][Full Text] [Related]
5. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
6. Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes.
Sakurai Y; Matsuda T; Hada T; Harashima H
Biol Pharm Bull; 2015; 38(8):1185-91. PubMed ID: 26235581
[TBL] [Abstract][Full Text] [Related]
7. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
8. Development of a multifunctional envelope-type nano device and its application to nanomedicine.
Sato Y; Nakamura T; Yamada Y; Harashima H
J Control Release; 2016 Dec; 244(Pt B):194-204. PubMed ID: 27374187
[TBL] [Abstract][Full Text] [Related]
9. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
10. Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.
Sato Y; Sakurai Y; Kajimoto K; Nakamura T; Yamada Y; Akita H; Harashima H
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27797146
[TBL] [Abstract][Full Text] [Related]
11. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system.
Kogure K; Akita H; Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):559-71. PubMed ID: 18037529
[TBL] [Abstract][Full Text] [Related]
13. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Kogure K
Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System.
Hayashi Y; Hatakeyama H; Kajimoto K; Hyodo M; Akita H; Harashima H
Bioconjug Chem; 2015 Jul; 26(7):1266-76. PubMed ID: 25938819
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
16. [Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
Kogure K; Akita H; Harashima H
Yakugaku Zasshi; 2008 Feb; 128(2):219-32. PubMed ID: 18239369
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo.
Kajimoto K; Sato Y; Nakamura T; Yamada Y; Harashima H
J Control Release; 2014 Sep; 190():593-606. PubMed ID: 24794902
[TBL] [Abstract][Full Text] [Related]
18. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
19. Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.
Yamada Y; Sato Y; Nakamura T; Harashima H
J Control Release; 2020 Nov; 327():533-545. PubMed ID: 32916227
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
